← Leaderboards
Nobuhiko Kamada
University Of Michigan At Ann Arbor
$8,201,108
Attributed
$9,469,974
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,469,974 · 6
By mechanism
R01$8,614,724 · 4
R21$855,250 · 2
Top collaborators
- James J. Moon4 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Grace Y. Chen$5,477,814
- Yatrik M Shah$14,576,569
- Janis M Miller$4,953,458
- Gary B. Huffnagle$14,751,708
- Daphna Oyserman$5,947,091
Others in their field
Top investigators on “Intestines”
- Richard S Blumberg · Children'S Hospital Boston$45,768,173
- Mark Donowitz · Johns Hopkins University$37,125,295
- Israel David Goldman · Yeshiva University$32,031,336
- Samuel A Wells · Duke University$31,864,469
- Margaret Rita Karagas · Dartmouth College$30,262,431
- Abhik Das · Research Triangle Institute$30,240,510
Research focus
IntestinesPathogenesisBacteriaInflammationAffectInflammatory Bowel DiseasesPathogenicityS DiseaseColitisMucous MembraneGut MicrobiotaChronicInsightBaseInflammatoryUnited StatesCrohn&AposLinkMicrobiotaReportingPathobiontIntestinal MucosaMouse ModelInterleukin-1 Beta
Grant awards (22)
The oral-gut axis in colorectal cancer$580,822
R01 · FY2025 · CA · contact PI
The role of IL-1Ã-inducing pathobionts in the pathogenesis of Crohnâs disease$495,526
R01 · FY2025 · DK · contact PI
The oral-gut axis in colorectal cancer$580,822
R01 · FY2024 · CA · contact PI
The role of IL-1Ã-inducing pathobionts in the pathogenesis of Crohnâs disease$475,706
R01 · FY2024 · DK · contact PI
Novel biomaterials for IBD treatment$634,433
R01 · FY2023 · DK
The role of IL-1Ã-inducing pathobionts in the pathogenesis of Crohnâs disease$495,526
R01 · FY2023 · DK · contact PI
Novel biomaterials for IBD treatment$634,433
R01 · FY2022 · DK
The link between oral bacteria and gut disease$391,108
R01 · FY2022 · DK · contact PI
Novel biomaterials for IBD treatment$634,433
R01 · FY2021 · DK
The link between oral bacteria and gut disease$391,108
R01 · FY2021 · DK · contact PI
The role of IL-1?-inducing pathobionts in the pathogenesis of Crohn?s disease$376,434
R01 · FY2021 · DK · contact PI
Novel biomaterials for IBD treatment$634,433
R01 · FY2020 · DK
The link between oral bacteria and gut disease$391,108
R01 · FY2020 · DK · contact PI
The role of IL-1?-inducing pathobionts in the pathogenesis of Crohn?s disease$376,434
R01 · FY2020 · DK · contact PI
Periodontitis and extra-oral mucosal inflammation$195,000
R21 · FY2020 · AI · contact PI
The link between oral bacteria and gut disease$391,108
R01 · FY2019 · DK · contact PI
The role of IL-1?-inducing pathobionts in the pathogenesis of Crohn?s disease$376,434
R01 · FY2019 · DK · contact PI
Periodontitis and extra-oral mucosal inflammation$234,000
R21 · FY2019 · AI · contact PI
The role of IL-1?-inducing pathobionts in the pathogenesis of Crohn?s disease$378,540
R01 · FY2018 · DK · contact PI
The role of IL-1?-inducing pathobionts in the pathogenesis of Crohn?s disease$376,316
R01 · FY2017 · DK · contact PI
Dietary amino acids control the competition between pathogenic and commensal E. coli in inflamed gut$232,500
R21 · FY2017 · DK · contact PI
Dietary amino acids control the competition between pathogenic and commensal E. coli in inflamed gut$193,750
R21 · FY2016 · DK · contact PI